Abstract:Since the report of "DNA untwisting" activity in 1972, ~50 years of research has revealed seven topoisomerases in humans (TOP1, TOP1mt, TOP2α, TOP2β, TOP3α, TOP3β and Spo11). These conserved regulators of DNA topology catalyze controlled breakage to the DNA backbone to relieve the torsional stress that accumulates during essential DNA transactions including DNA replication, transcription, and DNA repair. Each topoisomerase-catalyzed reaction involves the formation of a topoisomerase cleavage complex (TOPcc), a covalent protein-DNA reaction intermediate formed between the DNA phosphodiester backbone and a topoisomerase catalytic tyrosine residue. A variety of perturbations to topoisomerase reaction cycles can trigger failure of the enzyme to re-ligate the broken DNA strand(s), thereby generating topoisomerase DNA-protein crosslinks (TOP-DPC). TOP-DPCs pose unique threats to genomic integrity. These complex lesions are comprised of structurally diverse protein components covalently linked to genomic DNA, which are bulky DNA adducts that can directly impact progression of the transcription and DNA replication apparatus. A variety of genome maintenance pathways have evolved to recognize and resolve TOP-DPCs. Eukaryotic cells harbor tyrosyl DNA phosphodiesterases (TDPs) that directly reverse 3′-phosphotyrosyl (TDP1) and 5′-phoshotyrosyl (TDP2) protein-DNA linkages. The broad specificity Mre11-Rad50-Nbs1 and APE2 nucleases are also critical for mitigating topoisomerase-generated DNA damage. These DNA-protein crosslink metabolizing enzymes are further enabled by proteolytic degradation, with the proteasome, Spartan, GCNA, Ddi2, and FAM111A proteases implicated thus far. Strategies to target, unfold, and degrade the protein component of TOP-DPCs have evolved as well. Here we survey mechanisms for addressing Topoisomerase 1 (TOP1) and Topoisomerase 2 (TOP2) DPCs, highlighting systems for which molecular structure information has illuminated function of these critical DNA damage response pathways.

Crystal structure of the N-terminal region of human Topoisomerase IIβ binding protein 1.

Bioinformatic Analysis of Topoisomerase IIα Reveals Interdomain Interdependencies and Critical C-Terminal Domain Residues

BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability

Insights into the Dissociation Process and Binding Pattern of the BRCT7/8-PHF8 Complex

Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain

From the TOP: Formation, Recognition and Resolution of Topoisomerase DNA Protein Crosslinks

TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts

A Model for the Mechanism of Human Topoisomerase I

Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB

Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 PhosphopeptideImplications for Signaling

Type II topoisomerases shape multi-scale 3D chromatin folding in regions of positive supercoils

TopBP1 utilises a bipartite GINS binding mode to support genome replication

Topoisomerase IIb binding underlies frequently mutated elements in cancer genomes

Phosphorylation of the Brca1c Terminus (brct) Repeat Inhibitor of Htert (brit1) Protein Coordinates Topbp1 Protein Recruitment and Amplifies Ataxia Telangiectasia-Mutated and Rad3-Related (atr) Signaling

Consistent rationalization of type-2 topoisomerases' unknotting, decatenating, supercoil-relaxing actions and their scaling relation.

Human mitochondrial topoisomerase I

Human topoisomerases and their roles in genome stability and organization

Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIα Regulates Enzymatic Activity and Drug Sensitivity

Uncovering Novel Roles of Tandem BRCA1 C‐terminal (BRCT) Domains in DNA Repair, Genome Stability and Breast Cancer

Human Topoisomerase IIα Promotes Chromatin Condensation Via a Phase Transition